作者: Jamal Shamsara , Sara Lary , Javad Behravan , Marziyeh Lotfi , Sima Afsharnezhad
DOI: 10.1177/030089161109700118
关键词:
摘要: ABSTRACT Aims and background. Theprognosisofglioblastomamultiforme(GBM)remainspoordespiteadvancesinsurgeryandadjuvanttherapies. TP53 andO6-methylgua -nine-DNAmethyltransferase( MGMT )aretumorsuppressorgenesthatareimplicat-edinGBMresistancetoradiationandchemotherapy.Inordertoassesstheexpres-sionoftheproteinproductsofthesetwogenes,50GBMsampleswereanalyzedinthisstudy.Methods.Demographicandclinicaldataalongwithpostsurgerytumorsamplesfrom50GBMpatientswerecollectedfromthepathologyarchive.MGMTandp53proteinexpressionwasevaluatedbyimmunohistochemistry.Results. 52%ofcaseshadmutatedp53,predominantlyexpressedinthenucleioftu -morcells.MGMTimmunohistochemistrywasnegativein35(70%)patientsandpos-itivein15(30%)others.Immunohistochemistry-negativespecimensforMGMTex -pressionshowedasignificantlyhigherexpressionofmutantp53( P = 0.03).Conclusion. MGMTexpressionwassignificantlylowerincellsbearingp53mutation.Thisindicatesthatthereisatendencyforp53activitytodeclinewithMGMTinacti-vation.However,thisstudycouldnotdeducewhichproteinwastheregulatoroftheother.Freefulltextavailableatwww.tumorionline.itIntroductionAmongthemostcommoncancersinIran,braintumorsrankeleventh.Glioblas-tomamultiforme(GBM)isthemostaggressiveandthemostprevalent,witha53%in -cidencerate